SKU: SKU: C3 1203005
PZN: PZN: 17903048 / 17903054 / 17903077
CLEARTEST PSA rapid test for prostate cancer
Verpackungseinheit : 5 tests
Couldn't load pickup availability
The PSA rapid test for the early detection of prostate cancer is an advanced blood test for determining the level of prostate-specific antigen (PSA) in the blood. PSA is a protein found exclusively in prostate tissue and serves as an indicator of prostate diseases. The test provides rapid results and is an important tool in the early detection of prostate cancer, especially in cases of elevated PSA levels, which can indicate tumors or benign conditions.
Areas of application:
-
Early detection of prostate cancer
-
Monitoring PSA levels in patients with prostate cancer
-
Follow-up care after surgical procedures or oncological therapies
-
Detection of benign prostate diseases (e.g., enlarged prostate, prostatitis)
Advantages at a glance:
-
Fast results: The test result is available after only 5 minutes.
-
High sensitivity and specificity: The test has a sensitivity and specificity of over 99%, enabling reliable diagnostics.
-
Easy to use: The test is easy to perform and requires only a small amount of blood (whole blood, serum or plasma).
-
Diagnostic cut-off: The test has a diagnostic cut-off of 3 ng/ml to reliably identify suspicious PSA levels.
Further information:
-
The PSA level can also be elevated in benign prostate diseases such as prostate enlargement or prostatitis.
-
Men with PSA levels between 3 and 10 ng/ml should undergo a further prostate examination despite the result.
-
The test is used particularly by medical professionals to support the early detection and monitoring of prostate cancer.
Delivery information:
PZN: 17903048 / 17903054 / 17903077
WEEE number:
Assistive device number:
Manufacturer:
Servoprax GmbH
Am Marienbusch 9
46485 Wesel
Deutschland
Tel: +49 281 95283-05283-0
Email: info@servoprax.de
VAT ID number: DE120980351